The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study

Aliment Pharmacol Ther 2010; 32: 1343–1350 Summary Background  We lack population‐based estimates of the rate of decompensation in people with compensated cirrhosis as well as estimates of the manner in which the disease progresses once identified. Aim  To determine the rate of decompensation and cl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Alimentary pharmacology & therapeutics 2010-12, Vol.32 (11‐12), p.1343-1350
Hauptverfasser: Fleming, K. M., Aithal, G. P., Card, T. R., West, J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1350
container_issue 11‐12
container_start_page 1343
container_title Alimentary pharmacology & therapeutics
container_volume 32
creator Fleming, K. M.
Aithal, G. P.
Card, T. R.
West, J.
description Aliment Pharmacol Ther 2010; 32: 1343–1350 Summary Background  We lack population‐based estimates of the rate of decompensation in people with compensated cirrhosis as well as estimates of the manner in which the disease progresses once identified. Aim  To determine the rate of decompensation and clinical progression of disease in patients with cirrhosis based upon clinical symptoms recorded electronically in general practice data. Methods  Using Cox proportional hazards regression, we modelled the rate of decompensation for patients from the UK General Practice Research Database with a diagnosis of cirrhosis between 1987 and 2002. We determined the clinical progression in the first year following diagnosis and subsequently categorizing patients through time according to a simple clinical staging system agreed at the Baveno IV consensus conference. Results  The rate of decompensation in patients with compensated cirrhosis was found to be 11% overall. The rate of decompensation was higher in the first year (at 31% compared with 7.3% afterwards) and in patients with an alcoholic aetiology. Patients with compensated cirrhosis had a 1‐year probability of proceeding directly to death of 7% compared with 20% in patients with decompensated cirrhosis. Conclusions  Using data recorded in general practice records, it is possible to determine the rate of decompensation and the clinical progression of disease in people with cirrhosis.
doi_str_mv 10.1111/j.1365-2036.2010.04473.x
format Article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_00582718v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>762684706</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4823-de7159a60ea1c9fa981b38a8d0f896b57a052b5b4ffa9a16893bd546f4a16293</originalsourceid><addsrcrecordid>eNqNkU2P0zAQhi0EYsvCX0C-ILSHFH_EjoPEoVotLFIlOPRuTZzJ1lUaBzvd3f57HFrKFV_smfeZsT0vIZSzJc_r027JpVaFYFIvBctZVpaVXD6_IIuL8JIsmNB1IQyXV-RNSjvGmK6YeE2uBGeKCakX5GGzRRphQho62qIL-xGHBJMPA4Whpa73g3fQ0zGGh4gpzcKM-oSQkPqBjhjGHumTn7bU-Ri3Ifn0mQJ1YRviRNN0aI9vyasO-oTvzvs12Xy929zeF-sf377frtaFK42QRYsVVzVohsBd3UFteCMNmJZ1ptaNqoAp0aim7LIGXJtaNq0qdVfmQNTymtyc2m6ht2P0e4hHG8Db-9XazjnGlBEVN488sx9PbP7arwOmye59ctj3MGA4JFtpoU1ZMZ1JcyJdDClF7C6tObOzIXZn57nbee52NsT-McQ-59L350sOzR7bS-FfBzLw4QxAynPuIgzOp3-clForVWXuy4l78j0e__sBdvVzM5_kb-ywphA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>762684706</pqid></control><display><type>article</type><title>The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Wiley Free Content</source><creator>Fleming, K. M. ; Aithal, G. P. ; Card, T. R. ; West, J.</creator><creatorcontrib>Fleming, K. M. ; Aithal, G. P. ; Card, T. R. ; West, J.</creatorcontrib><description>Aliment Pharmacol Ther 2010; 32: 1343–1350 Summary Background  We lack population‐based estimates of the rate of decompensation in people with compensated cirrhosis as well as estimates of the manner in which the disease progresses once identified. Aim  To determine the rate of decompensation and clinical progression of disease in patients with cirrhosis based upon clinical symptoms recorded electronically in general practice data. Methods  Using Cox proportional hazards regression, we modelled the rate of decompensation for patients from the UK General Practice Research Database with a diagnosis of cirrhosis between 1987 and 2002. We determined the clinical progression in the first year following diagnosis and subsequently categorizing patients through time according to a simple clinical staging system agreed at the Baveno IV consensus conference. Results  The rate of decompensation in patients with compensated cirrhosis was found to be 11% overall. The rate of decompensation was higher in the first year (at 31% compared with 7.3% afterwards) and in patients with an alcoholic aetiology. Patients with compensated cirrhosis had a 1‐year probability of proceeding directly to death of 7% compared with 20% in patients with decompensated cirrhosis. Conclusions  Using data recorded in general practice records, it is possible to determine the rate of decompensation and the clinical progression of disease in people with cirrhosis.</description><identifier>ISSN: 0269-2813</identifier><identifier>EISSN: 1365-2036</identifier><identifier>DOI: 10.1111/j.1365-2036.2010.04473.x</identifier><identifier>PMID: 21050236</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adult ; Aged ; Biological and medical sciences ; Cohort Studies ; Digestive system ; Disease Progression ; Female ; Gastroenterology. Liver. Pancreas. Abdomen ; General Practice ; Humans ; Liver Cirrhosis - physiopathology ; Liver. Biliary tract. Portal circulation. Exocrine pancreas ; Male ; Medical sciences ; Middle Aged ; Other diseases. Semiology ; Pharmacology. Drug treatments ; Prognosis ; Regression Analysis ; Risk Factors ; Severity of Illness Index ; Survival Analysis ; Time Factors ; United Kingdom</subject><ispartof>Alimentary pharmacology &amp; therapeutics, 2010-12, Vol.32 (11‐12), p.1343-1350</ispartof><rights>2010 Blackwell Publishing Ltd</rights><rights>2015 INIST-CNRS</rights><rights>2010 Blackwell Publishing Ltd.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4823-de7159a60ea1c9fa981b38a8d0f896b57a052b5b4ffa9a16893bd546f4a16293</citedby><cites>FETCH-LOGICAL-c4823-de7159a60ea1c9fa981b38a8d0f896b57a052b5b4ffa9a16893bd546f4a16293</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-2036.2010.04473.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-2036.2010.04473.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,776,780,881,1411,1427,27903,27904,45553,45554,46387,46811</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23366557$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21050236$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-00582718$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Fleming, K. M.</creatorcontrib><creatorcontrib>Aithal, G. P.</creatorcontrib><creatorcontrib>Card, T. R.</creatorcontrib><creatorcontrib>West, J.</creatorcontrib><title>The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study</title><title>Alimentary pharmacology &amp; therapeutics</title><addtitle>Aliment Pharmacol Ther</addtitle><description>Aliment Pharmacol Ther 2010; 32: 1343–1350 Summary Background  We lack population‐based estimates of the rate of decompensation in people with compensated cirrhosis as well as estimates of the manner in which the disease progresses once identified. Aim  To determine the rate of decompensation and clinical progression of disease in patients with cirrhosis based upon clinical symptoms recorded electronically in general practice data. Methods  Using Cox proportional hazards regression, we modelled the rate of decompensation for patients from the UK General Practice Research Database with a diagnosis of cirrhosis between 1987 and 2002. We determined the clinical progression in the first year following diagnosis and subsequently categorizing patients through time according to a simple clinical staging system agreed at the Baveno IV consensus conference. Results  The rate of decompensation in patients with compensated cirrhosis was found to be 11% overall. The rate of decompensation was higher in the first year (at 31% compared with 7.3% afterwards) and in patients with an alcoholic aetiology. Patients with compensated cirrhosis had a 1‐year probability of proceeding directly to death of 7% compared with 20% in patients with decompensated cirrhosis. Conclusions  Using data recorded in general practice records, it is possible to determine the rate of decompensation and the clinical progression of disease in people with cirrhosis.</description><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Cohort Studies</subject><subject>Digestive system</subject><subject>Disease Progression</subject><subject>Female</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>General Practice</subject><subject>Humans</subject><subject>Liver Cirrhosis - physiopathology</subject><subject>Liver. Biliary tract. Portal circulation. Exocrine pancreas</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Other diseases. Semiology</subject><subject>Pharmacology. Drug treatments</subject><subject>Prognosis</subject><subject>Regression Analysis</subject><subject>Risk Factors</subject><subject>Severity of Illness Index</subject><subject>Survival Analysis</subject><subject>Time Factors</subject><subject>United Kingdom</subject><issn>0269-2813</issn><issn>1365-2036</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU2P0zAQhi0EYsvCX0C-ILSHFH_EjoPEoVotLFIlOPRuTZzJ1lUaBzvd3f57HFrKFV_smfeZsT0vIZSzJc_r027JpVaFYFIvBctZVpaVXD6_IIuL8JIsmNB1IQyXV-RNSjvGmK6YeE2uBGeKCakX5GGzRRphQho62qIL-xGHBJMPA4Whpa73g3fQ0zGGh4gpzcKM-oSQkPqBjhjGHumTn7bU-Ri3Ifn0mQJ1YRviRNN0aI9vyasO-oTvzvs12Xy929zeF-sf377frtaFK42QRYsVVzVohsBd3UFteCMNmJZ1ptaNqoAp0aim7LIGXJtaNq0qdVfmQNTymtyc2m6ht2P0e4hHG8Db-9XazjnGlBEVN488sx9PbP7arwOmye59ctj3MGA4JFtpoU1ZMZ1JcyJdDClF7C6tObOzIXZn57nbee52NsT-McQ-59L350sOzR7bS-FfBzLw4QxAynPuIgzOp3-clForVWXuy4l78j0e__sBdvVzM5_kb-ywphA</recordid><startdate>201012</startdate><enddate>201012</enddate><creator>Fleming, K. M.</creator><creator>Aithal, G. P.</creator><creator>Card, T. R.</creator><creator>West, J.</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><general>Wiley</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope></search><sort><creationdate>201012</creationdate><title>The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study</title><author>Fleming, K. M. ; Aithal, G. P. ; Card, T. R. ; West, J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4823-de7159a60ea1c9fa981b38a8d0f896b57a052b5b4ffa9a16893bd546f4a16293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Cohort Studies</topic><topic>Digestive system</topic><topic>Disease Progression</topic><topic>Female</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>General Practice</topic><topic>Humans</topic><topic>Liver Cirrhosis - physiopathology</topic><topic>Liver. Biliary tract. Portal circulation. Exocrine pancreas</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Other diseases. Semiology</topic><topic>Pharmacology. Drug treatments</topic><topic>Prognosis</topic><topic>Regression Analysis</topic><topic>Risk Factors</topic><topic>Severity of Illness Index</topic><topic>Survival Analysis</topic><topic>Time Factors</topic><topic>United Kingdom</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fleming, K. M.</creatorcontrib><creatorcontrib>Aithal, G. P.</creatorcontrib><creatorcontrib>Card, T. R.</creatorcontrib><creatorcontrib>West, J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>Alimentary pharmacology &amp; therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fleming, K. M.</au><au>Aithal, G. P.</au><au>Card, T. R.</au><au>West, J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study</atitle><jtitle>Alimentary pharmacology &amp; therapeutics</jtitle><addtitle>Aliment Pharmacol Ther</addtitle><date>2010-12</date><risdate>2010</risdate><volume>32</volume><issue>11‐12</issue><spage>1343</spage><epage>1350</epage><pages>1343-1350</pages><issn>0269-2813</issn><eissn>1365-2036</eissn><abstract>Aliment Pharmacol Ther 2010; 32: 1343–1350 Summary Background  We lack population‐based estimates of the rate of decompensation in people with compensated cirrhosis as well as estimates of the manner in which the disease progresses once identified. Aim  To determine the rate of decompensation and clinical progression of disease in patients with cirrhosis based upon clinical symptoms recorded electronically in general practice data. Methods  Using Cox proportional hazards regression, we modelled the rate of decompensation for patients from the UK General Practice Research Database with a diagnosis of cirrhosis between 1987 and 2002. We determined the clinical progression in the first year following diagnosis and subsequently categorizing patients through time according to a simple clinical staging system agreed at the Baveno IV consensus conference. Results  The rate of decompensation in patients with compensated cirrhosis was found to be 11% overall. The rate of decompensation was higher in the first year (at 31% compared with 7.3% afterwards) and in patients with an alcoholic aetiology. Patients with compensated cirrhosis had a 1‐year probability of proceeding directly to death of 7% compared with 20% in patients with decompensated cirrhosis. Conclusions  Using data recorded in general practice records, it is possible to determine the rate of decompensation and the clinical progression of disease in people with cirrhosis.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>21050236</pmid><doi>10.1111/j.1365-2036.2010.04473.x</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0269-2813
ispartof Alimentary pharmacology & therapeutics, 2010-12, Vol.32 (11‐12), p.1343-1350
issn 0269-2813
1365-2036
language eng
recordid cdi_hal_primary_oai_HAL_hal_00582718v1
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Wiley Free Content
subjects Adult
Aged
Biological and medical sciences
Cohort Studies
Digestive system
Disease Progression
Female
Gastroenterology. Liver. Pancreas. Abdomen
General Practice
Humans
Liver Cirrhosis - physiopathology
Liver. Biliary tract. Portal circulation. Exocrine pancreas
Male
Medical sciences
Middle Aged
Other diseases. Semiology
Pharmacology. Drug treatments
Prognosis
Regression Analysis
Risk Factors
Severity of Illness Index
Survival Analysis
Time Factors
United Kingdom
title The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T11%3A59%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20rate%20of%20decompensation%20and%20clinical%20progression%20of%20disease%20in%20people%20with%20cirrhosis:%20a%20cohort%20study&rft.jtitle=Alimentary%20pharmacology%20&%20therapeutics&rft.au=Fleming,%20K.%20M.&rft.date=2010-12&rft.volume=32&rft.issue=11%E2%80%9012&rft.spage=1343&rft.epage=1350&rft.pages=1343-1350&rft.issn=0269-2813&rft.eissn=1365-2036&rft_id=info:doi/10.1111/j.1365-2036.2010.04473.x&rft_dat=%3Cproquest_hal_p%3E762684706%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=762684706&rft_id=info:pmid/21050236&rfr_iscdi=true